NCT03718403View on ClinicalTrials.gov

Effect of Theophylline in Pseudohypoparathyroidism

PHASE4RecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

November 11, 2019

Primary Completion Date

April 10, 2030

Study Completion Date

April 10, 2032

Conditions
PHP IaPHP IBPhp1C
Interventions
DRUG

Theophylline

Theophylline will be given to maintain a peak level between 10-15 mcg/mL

Trial Locations (1)

02114

RECRUITING

Massachusetts General Hospital, Boston

All Listed Sponsors
lead

Massachusetts General Hospital

OTHER